## Gustilo Type II vs Type III: The Devascularization Criterion ### Core Distinction **Key Point:** The single most important discriminator between Gustilo Type II and Type III is **extensive soft tissue devascularization** — loss of blood supply to muscle and soft tissue that prevents primary wound closure and healing. ### Why Devascularization Matters **High-Yield:** Devascularization is the pathophysiological hallmark of Type III because it: - Prevents primary closure of the wound - Leads to tissue necrosis and infection - Requires staged reconstruction and possible amputation - Necessitates aggressive antibiotic coverage (including anaerobes) ### Gustilo Type II vs Type III: Detailed Comparison | Criterion | Type II | Type III | |-----------|---------|----------| | **Soft tissue damage** | Moderate | Extensive | | **Devascularization** | Absent | Present | | **Primary closure** | Usually possible | Not possible | | **Bone stripping** | Minimal to moderate | Extensive | | **Vascular injury** | Rare | Common | | **Infection risk** | 5–10% | 25–50% | | **Amputation risk** | < 5% | 10–50% | ### Clinical Pearl A Type II fracture may have a large laceration (up to 10 cm) and even vascular injury, but if soft tissue devascularization is absent and primary closure is achievable, it remains Type II. Conversely, a Type III fracture is defined by the **inability to achieve primary closure due to devascularization**, regardless of exact laceration size. ### Why Other Options Are Incomplete - **Laceration length** is a rough guide but not definitive; Type II can exceed 10 cm in some cases. - **Vascular injury** is common in Type III but not always present; some Type III fractures have intact vessels but extensive soft tissue stripping. - **Bone comminution** varies and is not the defining feature; soft tissue status determines the type. ### Management Algorithm ```mermaid flowchart TD A[Open fracture]:::outcome --> B{Assess soft tissue<br/>devascularization}:::decision B -->|Absent, primary<br/>closure possible| C[Type I or II]:::outcome B -->|Extensive,<br/>primary closure<br/>NOT possible| D[Type III]:::outcome C --> E[Primary closure<br/>+ antibiotics]:::action D --> F[Staged reconstruction<br/>+ aggressive antibiotics<br/>+ possible amputation]:::action ``` ### Antibiotic Regimen Differences **Type II:** Cephalosporin + Gentamicin **Type III:** Cephalosporin + Gentamicin + Clindamycin (anaerobic coverage) [cite:Rockwood & Green's Fractures in Adults 9e Ch 12] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.